Press Release

GBT Announces Participation at the 2018 Cantor Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the 2018 Cantor Global Healthcare Conference in New York City on Tuesday, October 2 at 1:05 p.m. Eastern Time.

The presentation will be webcast live and available for replay from GBT’s website at in the Investors section.

About GBT
GBT is a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities. GBT is developing two therapies for the potential treatment of sickle cell disease, including its late-stage product candidate, voxelotor, as an oral, once-daily therapy. To learn more, please visit and follow the company on Twitter @GBT_news.

Contact Information:

Myesha Lacy (investors)

Julie Normart (media)

GBT new logo.png

Global Blood Therapeutics, Inc.